CEO-TWO (Beutlich Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the CEO-TWO drug offered from Beutlich Pharmaceuticals, LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Beutlich Pharmaceuticals, LLC |
NON-PROPRIETARY NAME: | Laxative |
SUBSTANCE NAME: | POTASSIUM BITARTRATE; SODIUM BICARBONATE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | RECTAL |
DOSAGE FORM: | SUPPOSITORY |
MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
START MARKETING DATE: | 2008-08-15 |
END MARKETING DATE: | 0000-00-00 |
CEO-TWO HUMAN OTC DRUG Details:
Item Description | CEO-TWO from Beutlich Pharmaceuticals, LLC |
LABELER NAME: | Beutlich Pharmaceuticals, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 927; 618(mg/3.7g; mg/3.7g) |
START MARKETING DATE: | 2008-08-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0283-0808_fe0fc90b-8151-4cde-b7b9-461840203417 |
PRODUCT NDC: | 0283-0808 |
APPLICATION NUMBER: | part334 |
Other POTASSIUM BITARTRATE; SODIUM BICARBONATE Pharmaceutical Manufacturers / Labelers: